Research Article
Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis
Table 2
Comparison of biochemistry of diabetic cohort according to glycaemic control.
| | Variable | <5.4% | 5.4–7.9% | 8–9.9% | >10% | value | | <36 mmol/mol | 37–63 mmol/mol | 64–85 mmol/mol | >86 mmol/mol |
| | Urea (mmol/L) | 18.5 (10.8–21.5) | 16.8 (13.2–22.9) | 17.5 (12.8–21.3) | 17.5 (9.4–23.8) | 0.98 | | Creatinine (mol/L) | 682 (570–839) | 706 (571–845) | 710 (558–853) | 728 (624–854) | 0.77 | | Albumin (g/L) | 40 (37–43) | 40 (38–42) | 41 (38–43) | 40 (37–41) | 0.09 | | CRP (mg/L) | 6 (5–15) | 6 (5–20) | 6 (5–14) | 6 (5–17) | 0.87 | | Hb (g/dL) | 10.3 (8.9–11.2) | 10.6 (9.6–11.5) | 10.9 (10–11.7) | 11 (9.8–11.9) | 0.02 | | Ferritin (mcg/L) | 394 (195–571) | 445 (279–623) | 458 (291–647) | 496 (277–837) | 0.69 | | TSAT (%) | 22 (17–29) | 25 (21–32) | 26 (21–34) | 26 (21–35) | 0.2 | | Calcium (mmol/L) | 2.3 (2.2–2.4) | 2.3 (2.2–2.4) | 2.3 (2.2–2.4) | 2.2 (2.1–2.3) | 0.06 | | Phosphate (mmol/L) | 1.5 (1.3–1.9) | 1.4 (1.1–1.7) | 1.5 (1.2–1.9) | 1.5 (1.3–1.9) | 0.2 | | PTH (pmol/L) | 44 (36–91) | 40 (20–52) | 34 (16–57) | 41 (32–65) | 0.1 | | ALP (unit/L) | 99 (64–138) | 117 (85–162) | 104 (80–145) | 134 (91–224) | 0.01 | | Sodium (mmol/L) | 139 (138–141) | 138 (136–140) | 139 (137–141) | 138 (135–140) | 0.002 | | Bicarbonate (mmol/L) | 22 (20–23) | 22 (20–24) | 22 (20–24) | 22 (22–24) | 0.4 | | Potassium (mmol/L) | 5.1 (4.6–5.7) | 4.8 (4.5–5.5) | 4.9 (4.4–5.4) | 4.8 (4.5–5.5) | 0.5 | | Kt/V | 1.4 (1.4–1.8) | 1.5 (1.3–1.7) | 1.6 (1.4–1.7) | 1.4 (1.4–1.6) | 0.61 | | Pre-HD systolic BP (mm/Hg) | 141 (131–159) | 158 (138–175) | 150 (132–170) | 179 (133–202) | 0.02 |
|
|
